No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: RVXOT
Reply New Message
Prev Message Back To Forum Threaded View Next Message

No, I attempted to point out the Zenith stock listing on the Venture Exchange.

The stock ZENI-P-X description speels out ZEN-3694.

Zenith Capital Corp. (Instrument ExchangeTSX Venture: Instrument Symbol ZENI-P-X)

This cannot be so.

Koo

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply